Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

J.B. Chemicals & Pharmaceuticals Lt Call Transcript 2026

May 7, 2026

63696_rns_2026-05-07_3404815d-349d-402e-93f6-0d03f5059e11.pdf

Call Transcript

Open in viewer

Opens in your device viewer

JB

GOOD PEOPLE for GOOD HEALTH

May 7, 2026

National Stock Exchange of India Limited
Exchange Plaza, 5th Floor, Plot No. C/1,
G-Block, Bandra Kurla Complex,
Bandra (E), Mumbai – 400051.

Stock Symbol: JBCHEPHARM

Dear Sir,

Subject: Investors/analysts call with management

Ref.: Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company has scheduled a conference call for investors and analysts on Tuesday, May 12, 2026 at 8.30 a.m. IST to discuss its results and developments for the fourth quarter ended March 31, 2026.

All interested investors/ analysts may join using the following dial-in numbers:

Universal Dial-in Number (India): +91 22 6280 1439/ +91 22 7115 8803

International Numbers
Hong Kong Local Access Number: 800 964 448
Singapore Local Access Number: 800 101 2045
UK Local Access Number: 0 808 101 1573
USA Local Access Number: 1 866 746 2133

The document containing the link for registration and log-in to join the said conference call is attached herewith. Alternatively, the investor/analysts can also log on to the Company’s website www.jbpharma.com to register and join the said conference call.

Registered Office:
J. B. Chemicals & Pharmaceuticals Limited
CIN: L24390GJ1976PLC173077
302, Iscon Mall, Star India Bazar Building,
Opp. Jodhpur BRTS Satellite,
Ahmedabad- 380015, Gujarat, India

Corporate Office:
J. B. Chemicals & Pharmaceuticals Limited
CIN: L24390GJ1976PLC173077
Cnergy IT Park, Unit A2, 3rd Floor, Appa Saheb Marathe Marg,
Prabhadevi, Mumbai 400 025.
Tel.: +91 22 2439 5200/5500

www.jbpharma.com


JB

GOOD PEOPLE for GOOD HEALTH

The schedule of the meeting may change due to exigencies.

We request you to take this on record.

Thanking you,

Yours faithfully,

For J. B. Chemicals & Pharmaceuticals Ltd.

SANDEEP
ANIL
PHADNIS

Digitally signed by
SANDEEP ANIL
PHADNIS
Date: 2026.05.07
22:59:41 +05'30'

Sandeep Phadnis
Vice President – Secretarial
& Company Secretary

Registered Office:
J. B. Chemicals & Pharmaceuticals Limited
CIN: L24390GJ1976PLC173077
302, Iscon Mall, Star India Bazar Building,
Opp. Jodhpur BRTS Satellite,
Ahmedabad- 380015, Gujarat, India

Corporate Office:
J. B. Chemicals & Pharmaceuticals Limited
CIN: L24390GJ1976PLC173077
Cnergy IT Park, Unit A2, 3rd Floor, Appa Saheb Marathe Marg,
Prabhadevi, Mumbai 400 025.
Tel.: +91 22 2439 5200/5500

www.jbpharma.com


JB

GOOD PEOPLE

for GOOD HEALTH

JB Pharma Q4 FY26 Earnings Conference Call

on Tuesday, May 12, 2026 at 8:30 AM IST

J B Chemicals and Pharmaceuticals Ltd. (JB Pharma), one of the fastest growing pharmaceutical companies in India, will host a conference call for investors and analysts on Tuesday, May 12, 2026 at 8:30 AM IST to discuss its results and developments for the fourth quarter ended 31st March, 2026. The financial results will be announced on Monday, May 11, 2026.

The senior management of JB Pharma will be present to address the call.

Details of the conference call are as follows:
Timing 8:30-9:30 am IST on Tuesday, May 12, 2026
Pre-registration To enable participants to connect to the conference call without having to wait for an operator, please register at the below mentioned link.
Clink here to ExpressJoin the Call
You will receive dial in numbers, passcode and a pin for the concall on the registered email address provided by you. Kindly dial into the call on the Conference Call date and use the passcode & pin to connect to call.
Universal Dial-in Number (India) +91 22 6280 1439
+91 22 7115 8803
Hong Kong Local Access Number 800 964 448
Singapore Local Access Number 800 101 2045
UK Local Access Number 0 808 101 1573
USA Local Access Number 1 866 746 2133